Leukapheresis

Global Leukapheresis Market to Reach US$143.7 Million by 2030

The global market for Leukapheresis estimated at US$96.0 Million in the year 2024, is expected to reach US$143.7 Million by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$26.7 Million While China is Forecast to Grow at 6.5% CAGR

The Leukapheresis market in the U.S. is estimated at US$26.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.2 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Leukapheresis Market - Key Trends & Drivers Summarized

What Is Leukapheresis and Why Is It Gaining Importance in Medical Treatments?

Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from the blood, which is increasingly being used in the treatment of various diseases, including leukemia, multiple myeloma, and autoimmune disorders. This procedure is gaining importance due to its critical role in both therapeutic and research settings. In therapeutic applications, leukapheresis is used to reduce high white blood cell counts, which can be dangerous in certain cancer patients. In research, it is employed to collect leukocytes for use in developing and testing new therapies, such as CAR-T cell therapy. As the demand for advanced treatment options grows, leukapheresis is becoming an essential tool in the medical field.

How Are Technological Advancements Impacting the Leukapheresis Market?

Technological advancements are playing a significant role in the growth of the leukapheresis market. The development of more efficient and automated apheresis machines has made the procedure safer, faster, and more comfortable for patients. These advancements are also enabling higher yields of leukocytes, which is particularly important for the success of therapies like CAR-T cell therapy. Additionally, innovations in leukapheresis techniques are reducing the risk of complications and improving patient outcomes. As technology continues to evolve, it is expected to further enhance the efficacy and accessibility of leukapheresis, driving its adoption in both clinical and research settings.

What Role Does Leukapheresis Play in the Advancement of Cancer Therapies?

Leukapheresis is playing a crucial role in the advancement of cancer therapies, particularly in the development of immunotherapies such as CAR-T cell therapy. In this process, leukapheresis is used to collect T cells from the patient’s blood, which are then genetically modified to target and destroy cancer cells. This personalized approach to cancer treatment has shown promising results, especially in patients with certain types of leukemia and lymphoma. The increasing success of these therapies is driving demand for leukapheresis, as it is a critical step in the treatment process. As more immunotherapies are developed and approved, the use of leukapheresis is expected to expand, making it a key component in the future of cancer treatment.

What Factors Are Driving the Growth of the Leukapheresis Market?

The growth in the leukapheresis market is driven by several factors, including the increasing prevalence of cancer and autoimmune diseases, advancements in apheresis technology, and the rising demand for personalized medicine. The growing adoption of immunotherapies, which rely on leukapheresis for the collection of immune cells, is also a significant driver. Additionally, the expansion of clinical trials and research activities focused on developing new treatments is boosting the demand for leukapheresis procedures. As the medical community continues to explore new therapeutic applications and improve existing ones, the leukapheresis market is expected to experience sustained growth, driven by its critical role in advancing modern medical treatments.

SCOPE OF STUDY:

The report analyzes the Leukapheresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Offering (Devices, Disposables); Application (Research, Therapeutic); End-Use (Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies, Hospital & Transfusion Centers)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

• Allcells LLC
• Asahi Kasei Medical Co., Ltd.
• BioIVT
• Caltag Medsystems Limited
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• HemaCare Corporation
• Key Biologics, LLC.
• MacoPharma SA
• Ppa Research Group, Inc.
• Precision Medicine Group, Inc.
• StemCell Technologies Inc.
• StemExpress
• Terumo BCT, Inc.
• Zenbio, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.